These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20145081)

  • 1. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
    Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS
    Antimicrob Agents Chemother; 2010 May; 54(5):1678-83. PubMed ID: 20145081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.
    Ambrose PG; Forrest A; Craig WA; Rubino CM; Bhavnani SM; Drusano GL; Heine HS
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4351-5. PubMed ID: 17875992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
    Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP
    Antimicrob Agents Chemother; 2010 Mar; 54(3):991-6. PubMed ID: 20047912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Heine HS; Bassett J; Miller L; Bassett A; Ivins BE; Lehoux D; Arhin FF; Parr TR; Moeck G
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3350-7. PubMed ID: 18606841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hollow-fiber pharmacodynamic studies and mathematical modeling to predict the efficacy of amoxicillin for anthrax postexposure prophylaxis in pregnant women and children.
    Louie A; Vanscoy B; Liu W; Kulawy R; Drusano GL
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5946-60. PubMed ID: 24041894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omadacycline is active
    Heine HS; Drusano G; Purcell BK; Anastasiou D; Tanaka SK; Serio AW
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0059524. PubMed ID: 39133023
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Kao LM; Bush K; Barnewall R; Estep J; Thalacker FW; Olson PH; Drusano GL; Minton N; Chien S; Hemeryck A; Kelley MF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3535-42. PubMed ID: 17065619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis.
    Louie A; Heine HS; Kim K; Brown DL; VanScoy B; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2486-96. PubMed ID: 18458134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 11. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure therapy of inhalational anthrax in the common marmoset.
    Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
    Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid
    Lawrence WS; Peel JE; Slayden RA; Peterson JW; Baze WB; Hensel ME; Whorton EB; Beasley DWC; Cummings JE; Macias-Perez I
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0011224. PubMed ID: 38888319
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin for postexposure inhalational anthrax in pediatrics: rationale for dosing recommendations.
    Alexander JJ; Colangelo PM; Cooper CK; Roberts R; Rodriguez WJ; Murphy MD
    Pediatr Infect Dis J; 2008 Nov; 27(11):955-7. PubMed ID: 18833025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
    Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4471-3. PubMed ID: 20643899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
    Slay RM; Hewitt JA; Crumrine M
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S411-S416. PubMed ID: 36251550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.